Cardinal Health, Inc. (CAH) FY2025 Annual Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2024-07-01 to 2025-06-30

Swipe to see the full flow
Cardinal Health, Inc. cash flow reconciliation, Jul 1, 2024 through Jun 30, 2025One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net earnings → Net cash from operating activities: $1,569,000,000.00Increase in accounts payable → Operating adjustments reconciliation: $2,732,000,000.00Depreciation and amortization → Operating adjustments reconciliation: $790,000,000.00Share-based compensation → Operating adjustments reconciliation: $244,000,000.00Provision for/(benefit from) deferred income taxes → Operating adjustments reconciliation: $243,000,000.00Provision for bad debts → Operating adjustments reconciliation: $53,000,000.00Impairments and (gain)/loss on disposal of assets, net → Operating adjustments reconciliation: $18,000,000.00Impairments and loss on sale of other investments → Operating adjustments reconciliation: $3,000,000.00Operating adjustments reconciliation → Net cash from operating activities: $828,000,000.00Operating adjustments reconciliation → (Increase)/decrease in inventories: $1,816,000,000.00Operating adjustments reconciliation → Increase in trade receivables: $833,000,000.00Operating adjustments reconciliation → Other accrued liabilities and operating items, net: $606,000,000.00Proceeds from long-term obligations, net of issuance costs → financing reconciliation: $3,669,000,000.00financing reconciliation → Net cash from financing activities: $1,940,000,000.00financing reconciliation → Purchase of treasury shares: $765,000,000.00financing reconciliation → Dividends on common shares: $494,000,000.00financing reconciliation → Reduction of long-term obligations: $445,000,000.00financing reconciliation → Net tax proceeds/(withholding) from share-based compensation: $13,000,000.00financing reconciliation → Purchase of noncontrolling interests: $12,000,000.00Proceeds from short-term investment in time deposit → investing reconciliation: $200,000,000.00Proceeds from net investment hedge terminations → investing reconciliation: $2,000,000.00Increase (decrease) in other investing items, net → investing reconciliation: $2,000,000.00investing reconciliation → Acquisition of subsidiaries, net of cash acquired: $5,250,000,000.00investing reconciliation → Additions to property and equipment: $547,000,000.00Net cash used in investing activities → investing reconciliation: $5,593,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $5,133,000,000.00Net cash from operating activities → Cash sources and uses: $2,397,000,000.00Net cash from financing activities → Cash sources and uses: $1,940,000,000.00Cash sources and uses → Exchange-rate effect: $3,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $3,874,000,000.00Cash sources and uses → Net cash used in investing activities: $5,593,000,000.00Net earnings: $1,569,000,000.00Net earnings+$1.57 BDepreciation and amortization: $790,000,000.00Depreciation & amortization+$790.00 MImpairments and loss on sale of other investments: $3,000,000.00Other investment gain & loss+$3.00 MImpairments and (gain)/loss on disposal of assets, net: $18,000,000.00Asset sales & impairments+$18.00 MShare-based compensation: $244,000,000.00Stock-based compensation+$244.00 MProvision for/(benefit from) deferred income taxes: $243,000,000.00Deferred income taxes+$243.00 MProvision for bad debts: $53,000,000.00Credit loss provision+$53.00 MIncrease in trade receivables: -$833,000,000.00Receivables, net−$833.00 M(Increase)/decrease in inventories: -$1,816,000,000.00Inventories−$1.82 BIncrease in accounts payable: $2,732,000,000.00Accounts payable+$2.73 BOther accrued liabilities and operating items, net: -$606,000,000.00Other working capital, net−$606.00 MNet cash from operating activities: $2,397,000,000.00Operating cash+$2.40 BOperating adjustments reconciliation: $4,083,000,000.00Reduction of long-term obligations: -$445,000,000.00Long-term debt repaid−$445.00 MNet tax proceeds/(withholding) from share-based compensation: -$13,000,000.00Share-based tax withholding, net−$13.00 MDividends on common shares: -$494,000,000.00Common dividends paid−$494.00 MPurchase of treasury shares: -$765,000,000.00Common stock repurchases−$765.00 MPurchase of noncontrolling interests: -$12,000,000.00Paid to noncontrolling interests−$12.00 MProceeds from long-term obligations, net of issuance costs: $3,669,000,000.00Debt issued, net of costs+$3.67 BNet cash from financing activities: $1,940,000,000.00Financing cash+$1.94 Bfinancing reconciliation: $3,669,000,000.00Acquisition of subsidiaries, net of cash acquired: -$5,250,000,000.00Acquisitions, net of cash−$5.25 BAdditions to property and equipment: -$547,000,000.00PP&E purchases−$547.00 MProceeds from net investment hedge terminations: $2,000,000.00Investing hedge proceeds+$2.00 MPurchase of short-term time deposits: $0.00Proceeds from short-term investment in time deposit: $200,000,000.00Deposit proceeds+$200.00 MIncrease (decrease) in other investing items, net: $2,000,000.00Increase (decrease) in other investing items, net+$2.00 MNet cash used in investing activities: -$5,593,000,000.00. Cash required to fund net payments.Investing cash−$5.59 Binvesting reconciliation: $5,797,000,000.00Cash sources and uses: $9,470,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $5,133,000,000.00Beginning cash$5.13 BEnding cash: Cash, cash equivalents, and restricted cash: $3,874,000,000.00Ending cash$3.87 BExchange-rate effect: -$3,000,000.00FX effect−$3.00 MCASH RECONCILIATIONOperatingflowsFinancingflowsInvestingflowsFree cash flow$1.85 BOperating cash − cash spent on PP&ECash flow / Net income1.53×Operating cash flow ÷ net incomeNet cash change−$1.26 BEnding cash − beginning cash
Chart details

Cardinal Health, Inc. cash flow reconciliation, Jul 1, 2024 through Jun 30, 2025

Cash flows for Jul 1, 2024 through Jun 30, 2025. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Jun 30, 2024. Ending cash: Jun 30, 2025. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Jun 30, 2024
5,133,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
2,397,000,000 US dollars. Net cash provided.
Net earnings
1,569,000,000 US dollars
Depreciation and amortization
790,000,000 US dollars
Impairments and loss on sale of other investments
3,000,000 US dollars
Impairments and (gain)/loss on disposal of assets, net
18,000,000 US dollars
Share-based compensation
244,000,000 US dollars
Provision for/(benefit from) deferred income taxes
243,000,000 US dollars
Provision for bad debts
53,000,000 US dollars
Increase in trade receivables
negative 833,000,000 US dollars
(Increase)/decrease in inventories
negative 1,816,000,000 US dollars
Increase in accounts payable
2,732,000,000 US dollars
Other accrued liabilities and operating items, net
negative 606,000,000 US dollars
Investing activities
negative 5,593,000,000 US dollars. Net cash used.
Acquisition of subsidiaries, net of cash acquired
negative 5,250,000,000 US dollars
Additions to property and equipment
negative 547,000,000 US dollars
Proceeds from net investment hedge terminations
2,000,000 US dollars
Purchase of short-term time deposits
0 US dollars
Proceeds from short-term investment in time deposit
200,000,000 US dollars
Increase (decrease) in other investing items, net
2,000,000 US dollars
Financing activities
1,940,000,000 US dollars. Net cash provided.
Reduction of long-term obligations
negative 445,000,000 US dollars
Net tax proceeds/(withholding) from share-based compensation
negative 13,000,000 US dollars
Dividends on common shares
negative 494,000,000 US dollars
Purchase of treasury shares
negative 765,000,000 US dollars
Purchase of noncontrolling interests
negative 12,000,000 US dollars
Proceeds from long-term obligations, net of issuance costs
3,669,000,000 US dollars
Operating adjustment reconciliation
4,083,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
3,669,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
5,797,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 3,000,000 US dollars
Ending cash on Jun 30, 2025
3,874,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
9,470,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 1,259,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
1.53×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
2,397,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
547,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
1,850,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $828.00M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 2,397,000,000 US dollars minus 547,000,000 US dollars equals 1,850,000,000 US dollars.
Cardinal Health, Inc. (CAH) FY2025 Annual Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!